MoneyWorks4Me

Triochem Products informs about disclosure

12 Oct 2018 Evaluate

Triochem Products has informed about statement of deviation or variation in public issue, rights issue, preferential issue, etc. under Regulation 52(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended 30.09.2018.

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..